Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Cyclopentolate 0.5% and 1% single dose eye drops		Specialist ophthalmologist recommendation. Use by glaucoma surgeons for neovascular glaucoma.
Cyclopentolate hydrochloride 0.5% and 1% eye drops
Cyclopentolate hydrochloride 0.5% and 1% single dose		Specialist ophthalmologist recommendation
Cyproterone acetate
Cyproterone tablets
Danazol capsules		Hereditary angiodema (off label)
Dantrolene capsules
Dapagliflozin	TA679 - Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Degarelix injection	TA404 - Degarelix for treating advanced hormone-dependent prostate cancer	Supported by ESCA
Demeclocycline capsules		For the treatment of hyponatraemia resulting from inappropriate secretion of antidiuretic hormone. Unlicensed.

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.